IDEXX Common Stock Total Equity from 2010 to 2025

IDXX Stock  USD 459.86  3.80  0.82%   
IDEXX Laboratories Common Stock Total Equity yearly trend continues to be fairly stable with very little volatility. Common Stock Total Equity will likely drop to about 9 M in 2025. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
1999-09-30
Previous Quarter
10.7 M
Current Value
10.7 M
Quarterly Volatility
2.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 138.8 M, Interest Expense of 11 M or Total Revenue of 4.1 B, as well as many indicators such as Price To Sales Ratio of 9.17, Dividend Yield of 0.0 or PTB Ratio of 22.4. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
  
Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Latest IDEXX Laboratories' Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of IDEXX Laboratories over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. IDEXX Laboratories' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

IDEXX Common Stock Total Equity Regression Statistics

Arithmetic Mean10,031,310
Geometric Mean9,808,979
Coefficient Of Variation17.31
Mean Deviation892,142
Median10,428,000
Standard Deviation1,736,512
Sample Variance3T
Range8.3M
R-Value0.51
Mean Square Error2.4T
R-Squared0.26
Significance0.04
Slope185,739
Total Sum of Squares45.2T

IDEXX Common Stock Total Equity History

2025M
202412.3 M
202210.7 M
202110.7 M
202010.6 M
201910.6 M
201810.5 M

About IDEXX Laboratories Financial Statements

IDEXX Laboratories investors use historical fundamental indicators, such as IDEXX Laboratories' Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity12.3 MM

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.